Global Opioids Drugs Professional Survey Report 2024, Forecast to 2029
Opioids are a class of drugs naturally found in the opium poppy plant and that work in the brain to produce a variety of effects
Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.
We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.
The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.
We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.
The report will conduct a comprehensive and professional analysis of the Opioids Drugs market in 2024 based on the current situation, global economic impact and other aspects.
Market Segment by Product Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market Segment by Product Application
Pain Relief
Anesthesia
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Purdue Pharma
Pfizer
Mylan
J&J
Endo
Teva
Mallinckrodt
INSYS
Depomed
Hikma
Pernix
Egalet
Vistapharm
Insights and Tools:
This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.
The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.
Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To define, describe and forecast the Opioids Drugs market by type, application, end user and region
2.Provide enterprise external environment analysis and SWOT analysis
3.Focuses on the key global Opioids Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.
4.Provide market entry strategy analysis for new players or players preparing to enter the market
5.Keep up with international market trends and analyze the impact of the important international events on major global regions
6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape
Global Opioids Drugs Professional Survey Report Report 2024, Forecast to 2029
1 Market Study Overview
1.1 Study Objectives
1.2 Opioids Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Opioids Drugs Segment by Type
2.1.1 Oxycodone
2.1.2 Hydromorphone
2.1.3 Codeine
2.1.4 Fentanyl
2.1.5 Other
2.2 Market Analysis by Application
2.2.1 Pain Relief
2.2.2 Anesthesia
2.2.3 Other
2.3 Global Opioids Drugs Market Comparison by Regions (2019-2029)
2.3.1 Global Opioids Drugs Market Size (2019-2029)
2.3.2 North America Opioids Drugs Status and Prospect (2019-2029)
2.3.3 Europe Opioids Drugs Status and Prospect (2019-2029)
2.3.4 Asia-pacific Opioids Drugs Status and Prospect (2019-2029)
2.3.5 South America Opioids Drugs Status and Prospect (2019-2029)
2.3.6 Middle East & Africa Opioids Drugs Status and Prospect (2019-2029)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Opioids Drugs Industry Impact
2.5.1 Opioids Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Opioids Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Opioids Drugs Sales and Market Share by Manufacturer (2019-2024)
3.2 Global Opioids Drugs Revenue and Market Share by Manufacturer (2019-2024)
3.3 Global Opioids Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Opioids Drugs Manufacturer Market Share
3.5 Top 10 Opioids Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Opioids Drugs Market
3.7 Key Manufacturers Opioids Drugs Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Opioids Drugs Industry Key Manufacturers
4.1 Purdue Pharma
4.1.1 Company Details
4.1.2 Purdue Pharma Opioids Drugs Product Introduction, Application and Specification
4.1.3 Purdue Pharma Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.1.4 Main Business Overview
4.1.5 Purdue Pharma News
4.2 Pfizer
4.2.1 Company Details
4.2.2 Pfizer Opioids Drugs Product Introduction, Application and Specification
4.2.3 Pfizer Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.2.4 Main Business Overview
4.2.5 Pfizer News
4.3 Mylan
4.3.1 Company Details
4.3.2 Mylan Opioids Drugs Product Introduction, Application and Specification
4.3.3 Mylan Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.3.4 Main Business Overview
4.3.5 Mylan News
4.4 J&J
4.4.1 Company Details
4.4.2 J&J Opioids Drugs Product Introduction, Application and Specification
4.4.3 J&J Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.4.4 Main Business Overview
4.4.5 J&J News
4.5 Endo
4.5.1 Company Details
4.5.2 Endo Opioids Drugs Product Introduction, Application and Specification
4.5.3 Endo Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.5.4 Main Business Overview
4.5.5 Endo News
4.6 Teva
4.6.1 Company Details
4.6.2 Teva Opioids Drugs Product Introduction, Application and Specification
4.6.3 Teva Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.6.4 Main Business Overview
4.6.5 Teva News
4.7 Mallinckrodt
4.7.1 Company Details
4.7.2 Mallinckrodt Opioids Drugs Product Introduction, Application and Specification
4.7.3 Mallinckrodt Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.7.4 Main Business Overview
4.7.5 Mallinckrodt News
4.8 INSYS
4.8.1 Company Details
4.8.2 INSYS Opioids Drugs Product Introduction, Application and Specification
4.8.3 INSYS Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.8.4 Main Business Overview
4.8.5 INSYS News
4.9 Depomed
4.9.1 Company Details
4.9.2 Depomed Opioids Drugs Product Introduction, Application and Specification
4.9.3 Depomed Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.9.4 Main Business Overview
4.9.5 Depomed News
4.10 Hikma
4.10.1 Company Details
4.10.2 Hikma Opioids Drugs Product Introduction, Application and Specification
4.10.3 Hikma Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.10.4 Main Business Overview
4.10.5 Hikma News
4.11 Pernix
4.11.1 Company Details
4.11.2 Pernix Opioids Drugs Product Introduction, Application and Specification
4.11.3 Pernix Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.11.4 Main Business Overview
4.11.5 Pernix News
4.12 Egalet
4.12.1 Company Details
4.12.2 Egalet Opioids Drugs Product Introduction, Application and Specification
4.12.3 Egalet Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.12.4 Main Business Overview
4.12.5 Egalet News
4.13 Vistapharm
4.13.1 Company Details
4.13.2 Vistapharm Opioids Drugs Product Introduction, Application and Specification
4.13.3 Vistapharm Opioids Drugs Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.13.4 Main Business Overview
4.13.5 Vistapharm News
5 Global Opioids Drugs Sales Categorized by Regions
5.1 Global Opioids Drugs Revenue, Sales and Market Share by Regions
5.1.1 Global Opioids Drugs Sales and Market Share by Regions (2019-2024)
5.1.2 Global Opioids Drugs Revenue and Market Share by Regions (2019-2024)
5.2 North America Opioids Drugs Sales and Growth Rate (2019-2024)
5.3 Europe Opioids Drugs Sales and Growth Rate (2019-2024)
5.4 Asia-pacific Opioids Drugs Sales and Growth Rate (2019-2024)
5.5 South America Opioids Drugs Sales and Growth Rate (2019-2024)
5.6 Middle East & Africa Opioids Drugs Sales and Growth Rate (2019-2024)
6 North America Opioids Drugs Market Size Categorized by Countries
6.1 North America Opioids Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Opioids Drugs Sales (Volume) by Countries (2019-2024)
6.1.2 North America Opioids Drugs Revenue by Countries (2019-2024)
6.1.3 United States Opioids Drugs Sales and Growth Rate (2019-2024)
6.1.4 Canada Opioids Drugs Sales and Growth Rate (2019-2024)
6.1.5 Mexico Opioids Drugs Sales and Growth Rate (2019-2024)
6.2 North America Opioids Drugs Revenue (Value) by Manufacturers
6.3 North America Opioids Drugs Sales and Market Share by Type (2019-2024)
6.4 North America Opioids Drugs Sales Market Share by Application (2019-2024)
7 Europe Opioids Drugs Market Size Categorized by Countries
7.1 Europe Opioids Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Opioids Drugs Sales (Volume) by Countries (2019-2024)
7.1.2 Europe Opioids Drugs Revenue by Countries (2019-2024)
7.1.3 Germany Opioids Drugs Sales and Growth Rate (2019-2024)
7.1.4 UK Opioids Drugs Sales and Growth Rate (2019-2024)
7.1.5 France Opioids Drugs Sales and Growth Rate (2019-2024)
7.1.6 Russia Opioids Drugs Sales and Growth Rate (2019-2024)
7.1.7 Italy Opioids Drugs Sales and Growth Rate (2019-2024)
7.1.8 Spain Opioids Drugs Sales and Growth Rate (2019-2024)
7.2 Europe Opioids Drugs Revenue (Value) by Manufacturers
7.3 Europe Opioids Drugs Sales and Market Share by Type (2019-2024)
7.4 Europe Opioids Drugs Sales Market Share by Application (2019-2024)
8 Asia-Pacific Opioids Drugs Market Size Categorized by Countries
8.1 Asia-pacific Opioids Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Opioids Drugs Sales (Volume) by Countries (2019-2024)
8.1.2 Asia-pacific Opioids Drugs Revenue by Countries (2019-2024)
8.1.3 China Opioids Drugs Sales and Growth Rate (2019-2024)
8.1.4 South Korea Opioids Drugs Sales and Growth Rate (2019-2024)
8.1.5 Japan Opioids Drugs Sales and Growth Rate (2019-2024)
8.1.6 Australia Opioids Drugs Sales and Growth Rate (2019-2024)
8.1.7 India Opioids Drugs Sales and Growth Rate (2019-2024)
8.1.8 Southeast Asia Opioids Drugs Sales and Growth Rate (2019-2024)
8.2 Asia-pacific Opioids Drugs Revenue (Value) by Manufacturers
8.3 Asia-pacific Opioids Drugs Sales and Market Share by Type (2019-2024)
8.4 Asia-pacific Opioids Drugs Sales Market Share by Application (2019-2024)
9 South America Opioids Drugs Market Size Categorized by Countries
9.1 South America Opioids Drugs Sales, Revenue and Market Share by Countries
9.1.1 South America Opioids Drugs Sales (Volume) by Countries (2019-2024)
9.1.2 South America Opioids Drugs Revenue by Countries (2019-2024)
9.1.3 Brazil Opioids Drugs Sales and Growth Rate (2019-2024)
9.2 South America Opioids Drugs Sales and Market Share by Type (2019-2024)
9.3 South America Opioids Drugs Sales Market Share by Application (2019-2024)
10 Middle East and Africa Opioids Drugs Market Size Categorized by Countries
10.1 Middle East and Africa Opioids Drugs Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Opioids Drugs Sales (Volume) by Countries (2019-2024)
10.1.2 Middle East and Africa Opioids Drugs Revenue by Countries (2019-2024)
10.1.3 GCC Countries Opioids Drugs Sales and Growth Rate (2019-2024)
10.1.4 Turkey Opioids Drugs Sales and Growth Rate (2019-2024)
10.1.5 Egypt Opioids Drugs Sales and Growth Rate (2019-2024)
10.1.6 South America Opioids Drugs Sales and Growth Rate (2019-2024)
10.2 Middle East and Africa Opioids Drugs Sales and Market Share by Type
10.3 Middle East and Africa Opioids Drugs Sales Market Share by Application (2019-2024)
11 Global Opioids Drugs Market Segment by Type
11.1 Global Opioids Drugs Revenue, Sales and Market Share by Type (2019-2024)
11.1.1 Global Opioids Drugs Sales and Market Share by Type (2019-2024)
11.1.2 Global Opioids Drugs Revenue and Market Share by Type (2019-2024)
11.2 Oxycodone Sales Growth Rate and Price
11.2.1 Global Oxycodone Sales Growth Rate (2019-2024)
11.2.2 Global Oxycodone Price (2019-2024)
11.3 Hydromorphone Sales Growth Rate and Price
11.3.1 Global Hydromorphone Sales Growth Rate (2019-2024)
11.3.2 Global Hydromorphone Price (2019-2024)
11.4 Codeine Sales Growth Rate and Price
11.4.1 Global Codeine Sales Growth Rate (2019-2024)
11.4.2 Global Codeine Price (2019-2024)
11.5.1 Global Fentanyl Sales Growth Rate (2019-2024)
11.5.2 Global Fentanyl Price (2019-2024)
11.6 Other Sales Growth Rate and Price
11.6.1 Global Other Sales Growth Rate (2019-2024)
11.6.2 Global Other Price (2019-2024)
12 Global Opioids Drugs Market Segment by Application
12.1 Global Opioids Drugs Sales Market Share by Application (2019-2024)
12.2 Pain Relief Sales Growth Rate (2019-2024)
12.3 Anesthesia Sales Growth Rate (2019-2024)
12.4 Other Sales Growth Rate (2019-2024)
13 Global Opioids Drugs Market Forecast
13.1 Global Opioids Drugs Revenue, Sales and Growth Rate (2024-2029)
13.2 Opioids Drugs Market Forecast by Regions (2024-2029)
13.2.1 North America Opioids Drugs Market Forecast (2024-2029)
13.2.2 Europe Opioids Drugs Market Forecast (2024-2029)
13.2.3 Asia-Pacific Opioids Drugs Market Forecast (2024-2029)
13.2.4 South America Opioids Drugs Market Forecast (2024-2029)
13.2.5 Middle East & Africa Opioids Drugs Market Forecast (2024-2029)
13.3 Opioids Drugs Market Forecast by Type (2024-2029)
13.3.1 Global Opioids Drugs Sales Forecast by Type (2024-2029)
13.3.2 Global Opioids Drugs Market Share Forecast by Type (2024-2029)
13.4 Opioids Drugs Market Forecast by Application (2024-2029)
13.4.1 Global Opioids Drugs Sales Forecast by Application (2024-2029)
13.4.2 Global Opioids Drugs Market Share Forecast by Application (2024-2029)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Opioids Drugs Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Opioids Drugs Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Opioids Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Opioids Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Opioids Drugs Market Size by Type
Figure Global Market Share of Opioids Drugs by Type in 2023
Figure Oxycodone Picture
Figure Hydromorphone Picture
Figure Codeine Picture
Figure Fentanyl Picture
Figure Other Picture
Table Global Opioids Drugs Market Size (Volume) by Application
Figure Pain Relief Picture
Figure Anesthesia Picture
Figure Other Picture
Table Global Opioids Drugs Comparison by Regions (M USD) 2019-2029
Figure Global Opioids Drugs Market Size (Million US$) (2019-2029)
Figure North America Opioids Drugs Revenue (Million US$) Growth Rate (2019-2029)
Figure Europe Opioids Drugs Revenue (Million US$) Growth Rate (2019-2029)
Figure Asia-pacific Opioids Drugs Revenue (Million US$) Growth Rate (2019-2029)
Figure South America Opioids Drugs Revenue (Million US$) Growth Rate (2019-2029)
Figure Middle East & Africa Opioids Drugs Revenue (Million US$) Growth Rate (2019-2029)
Table Business Impact Assessment - Covid-19
Table Market Trends and Opioids Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Opioids Drugs Sales by Manufacturer (2019-2024)
Figure Global Opioids Drugs Sales Market Share by Manufacturer in 2023
Table Global Opioids Drugs Revenue by Manufacturer (2019-2024)
Figure Global Opioids Drugs Revenue Market Share by Manufacturer in 2023
Table Global Opioids Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Opioids Drugs Manufacturer (Revenue) Market Share in 2023
Figure Top 10 Opioids Drugs Manufacturer (Revenue) Market Share in 2023
Table Date of Key Manufacturers Enter into Opioids Drugs Market
Table Key Manufacturers Opioids Drugs Product Type
Table Mergers & Acquisitions Planning
Table Purdue Pharma Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Purdue Pharma
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Purdue Pharma 2019-2024
Table Purdue Pharma Main Business
Table Purdue Pharma Recent Development
Table Pfizer Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Pfizer
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2019-2024
Table Pfizer Main Business
Table Pfizer Recent Development
Table Mylan Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Mylan
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2019-2024
Table Mylan Main Business
Table Mylan Recent Development
Table J&J Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of J&J
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of J&J 2019-2024
Table J&J Main Business
Table J&J Recent Development
Table Endo Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Endo
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Endo 2019-2024
Table Endo Main Business
Table Endo Recent Development
Table Teva Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Teva
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2019-2024
Table Teva Main Business
Table Teva Recent Development
Table Mallinckrodt Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Mallinckrodt
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mallinckrodt 2019-2024
Table Mallinckrodt Main Business
Table Mallinckrodt Recent Development
Table INSYS Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of INSYS
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of INSYS 2019-2024
Table INSYS Main Business
Table INSYS Recent Development
Table Depomed Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Depomed
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Depomed 2019-2024
Table Depomed Main Business
Table Depomed Recent Development
Table Hikma Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Hikma
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hikma 2019-2024
Table Hikma Main Business
Table Hikma Recent Development
Table Pernix Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Pernix
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pernix 2019-2024
Table Pernix Main Business
Table Pernix Recent Development
Table Egalet Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Egalet
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Egalet 2019-2024
Table Egalet Main Business
Table Egalet Recent Development
Table Vistapharm Company Profile
Table Opioids Drugs Product Introduction, Application and Specification of Vistapharm
Table Opioids Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Vistapharm 2019-2024
Table Vistapharm Main Business
Table Vistapharm Recent Development
Figure Global Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Global Opioids Drugs Revenue and Growth Rate (2019-2024)
Table Global Opioids Drugs Sales by Regions (2019-2024)
Figure Global Opioids Drugs Sales Market Share by Regions in 2023
Table Global Opioids Drugs Revenue by Regions (2019-2024)
Figure Global Opioids Drugs Revenue Market Share by Regions in 2023
Figure North America Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Europe Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Asia-pacific Opioids Drugs Sales and Growth Rate (2019-2024)
Figure South America Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Middle East & Africa Opioids Drugs Sales and Growth Rate (2019-2024)
Figure North America Opioids Drugs Revenue and Growth Rate (2019-2024)
Table North America Opioids Drugs Sales (Volume) by Countries (2019-2024)
Table North America Opioids Drugs Sales Market Share by Countries (2019-2024)
Figure North America Opioids Drugs Sales Market Share by Countries in 2023
Table North America Opioids Drugs Revenue by Countries (2019-2024)
Table North America Opioids Drugs Revenue Market Share by Countries (2019-2024)
Figure North America Opioids Drugs Revenue Market Share by Countries in 2023
Figure United States Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Canada Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Mexico Opioids Drugs Sales and Growth Rate (2019-2024)
Table North America Opioids Drugs Revenue by Manufacturer (2023)
Figure North America Opioids Drugs Revenue Market Share by Manufacturer in 2023
Table North America Opioids Drugs Sales by Type (2019-2024)
Table North America Opioids Drugs Sales Share by Type (2019-2024)
Table North America Opioids Drugs Sales by Application (2019-2024)
Table North America Opioids Drugs Sales Share by Application (2019-2024)
Figure Europe Opioids Drugs Revenue and Growth Rate (2019-2024)
Table Europe Opioids Drugs Sales (Volume) by Countries (2019-2024)
Table Europe Opioids Drugs Sales Market Share by Countries (2019-2024)
Figure Europe Opioids Drugs Sales Market Share by Countries in 2023
Table Europe Opioids Drugs Revenue by Countries (2019-2024)
Table Europe Opioids Drugs Revenue Market Share by Countries (2019-2024)
Figure Europe Opioids Drugs Revenue Market Share by Countries in 2023
Figure Germany Opioids Drugs Sales and Growth Rate (2019-2024)
Figure UK Opioids Drugs Sales and Growth Rate (2019-2024)
Figure France Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Russia Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Italy Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Spain Opioids Drugs Sales and Growth Rate (2019-2024)
Table Europe Opioids Drugs Revenue by Manufacturer (2023)
Figure Europe Opioids Drugs Revenue Market Share by Manufacturer in 2023
Table Europe Opioids Drugs Sales by Type (2019-2024)
Table Europe Opioids Drugs Sales Share by Type (2019-2024)
Table Europe Opioids Drugs Sales by Application (2019-2024)
Table Europe Opioids Drugs Sales Share by Application (2019-2024)
Figure Asia-pacific Opioids Drugs Revenue and Growth Rate (2019-2024)
Table Asia-pacific Opioids Drugs Sales (Volume) by Countries (2019-2024)
Table Asia-pacific Opioids Drugs Sales Market Share by Countries (2019-2024)
Figure Asia-pacific Opioids Drugs Sales Market Share by Countries in 2023
Table Asia-pacific Opioids Drugs Revenue by Countries (2019-2024)
Table Asia-pacific Opioids Drugs Revenue Market Share by Countries (2019-2024)
Figure Asia-pacific Opioids Drugs Revenue Market Share by Countries in 2023
Figure China Opioids Drugs Sales and Growth Rate (2019-2024)
Figure South Korea Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Japan Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Australia Opioids Drugs Sales and Growth Rate (2019-2024)
Figure India Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Southeast Asia Opioids Drugs Sales and Growth Rate (2019-2024)
Table Asia-pacific Opioids Drugs Revenue by Manufacturer (2023)
Figure Asia-pacific Opioids Drugs Revenue Market Share by Manufacturer in 2023
Table Asia-pacific Opioids Drugs Sales by Type (2019-2024)
Table Asia-pacific Opioids Drugs Sales Share by Type (2019-2024)
Table Asia-pacific Opioids Drugs Sales by Application (2019-2024)
Table Asia-pacific Opioids Drugs Sales Share by Application (2019-2024)
Figure South America Opioids Drugs Revenue and Growth Rate (2019-2024)
Table South America Opioids Drugs Sales (Volume) by Countries (2019-2024)
Table South America Opioids Drugs Sales Market Share by Countries (2019-2024)
Figure South America Opioids Drugs Sales Market Share by Countries in 2023
Table South America Opioids Drugs Revenue by Countries (2019-2024)
Table South America Opioids Drugs Revenue Market Share by Countries (2019-2024)
Figure South America Opioids Drugs Revenue Market Share by Countries in 2023
Figure Brazil Opioids Drugs Sales and Growth Rate (2019-2024)
Table South America Opioids Drugs Sales by Type (2019-2024)
Table South America Opioids Drugs Sales Share by Type (2019-2024)
Table South America Opioids Drugs Revenue by Type (2019-2024)
Table South America Opioids Drugs Revenue Share by Type (2019-2024)
Table South America Opioids Drugs Sales by Application (2019-2024)
Table South America Opioids Drugs Sales Share by Application (2019-2024)
Figure Middle East and Africa Opioids Drugs Revenue and Growth Rate (2019-2024)
Table Middle East and Africa Opioids Drugs Sales (Volume) by Countries (2019-2024)
Table Middle East and Africa Opioids Drugs Sales Market Share by Countries (2019-2024)
Figure Middle East and Africa Opioids Drugs Sales Market Share by Countries in 2023
Table Middle East and Africa Opioids Drugs Revenue by Countries (2019-2024)
Table Middle East and Africa Opioids Drugs Revenue Market Share by Countries (2019-2024)
Figure Middle East and Africa Opioids Drugs Revenue Market Share by Countries in 2023
Figure GCC Countries Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Turkey Opioids Drugs Sales and Growth Rate (2019-2024)
Figure Egypt Opioids Drugs Sales and Growth Rate (2019-2024)
Figure South Africa Opioids Drugs Sales and Growth Rate (2019-2024)
Table Middle East and Africa Opioids Drugs Sales by Type (2019-2024)
Table Middle East and Africa Opioids Drugs Sales Share by Type (2019-2024)
Table Middle East and Africa Opioids Drugs Revenue by Type (2019-2024)
Table Middle East and Africa Opioids Drugs Revenue Share by Type (2019-2024)
Table Middle East and Africa Opioids Drugs Sales by Application (2019-2024)
Table Middle East and Africa Opioids Drugs Sales Share by Application (2019-2024)
Table Global Opioids Drugs Sales by Type (2019-2024)
Table Global Opioids Drugs Sales Market Share by Type (2019-2024)
Figure Global Opioids Drugs Sales Market Share by Type in 2023
Table Global Opioids Drugs Revenue by Type (2019-2024)
Table Global Opioids Drugs Revenue Market Share by Type (2019-2024)
Figure Global Opioids Drugs Revenue Market Share by Type in 2023
Figure Global Oxycodone Sales Growth Rate (2019-2024)
Figure Global Oxycodone Price (2019-2024)
Figure Global Hydromorphone Sales Growth Rate (2019-2024)
Figure Global Hydromorphone Price (2019-2024)
Figure Global Codeine Sales Growth Rate (2019-2024)
Figure Global Codeine Price (2019-2024)
Figure Global Fentanyl Sales Growth Rate (2019-2024)
Figure Global Fentanyl Price (2019-2024)
Figure Global Other Sales Growth Rate (2019-2024)
Figure Global Other Price (2019-2024)
Table Global Opioids Drugs Sales by Application (2019-2024)
Table Global Opioids Drugs Sales Market Share by Application (2019-2024)
Figure Global Opioids Drugs Sales Market Share by Application in 2023
Figure Global Pain Relief Sales Growth Rate (2019-2024)
Figure Global Anesthesia Sales Growth Rate (2019-2024)
Figure Global Other Sales Growth Rate (2019-2024)
Figure Global Opioids Drugs Sales and Growth Rate (2024-2029)
Figure Global Opioids Drugs Revenue and Growth Rate (2024-2029)
Table Global Opioids Drugs Sales Forecast by Regions (2024-2029)
Table Global Opioids Drugs Market Share Forecast by Regions (2024-2029)
Figure North America Sales Opioids Drugs Market Forecast (2024-2029)
Figure Europe Sales Opioids Drugs Market Forecast (2024-2029)
Figure Asia-Pacific Sales Opioids Drugs Market Forecast (2024-2029)
Figure South America Sales Opioids Drugs Market Forecast (2024-2029)
Figure Middle East & Africa Sales Opioids Drugs Market Forecast (2024-2029)
Table Global Opioids Drugs Sales Forecast by Type (2024-2029)
Table Global Opioids Drugs Market Share Forecast by Type (2024-2029)
Table Global Opioids Drugs Sales Forecast by Application (2024-2029)
Table Global Opioids Drugs Market Share Forecast by Application (2024-2029)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioids Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|